AQR Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.1K Buy
12,378
+796
+7% +$1.68K ﹤0.01% 3272
2025
Q1
$14.1K Buy
+11,582
New +$14.1K ﹤0.01% 3137